Fortner RW

Language: English
References: 6
Page: 5
PDF size: 82.55 Kb.

Text Extraction

To the Editor:

MEDICC Review deserves accolades for presenting to the medical community information that has been poorly represented and even more poorly understood on the availability of meningococcal meningitis vaccines (Sotolongo F et al. Cuban Meningococcal BC Vaccine: Experiences & Contributions from 20 Years of Application. MEDICC Review, Fall 2007).

REFERENCES

1. Davis BT, Pasternack MS. Case 19-2007 - A 19-year-old college student with fever and joint pain. Case records of the Massachusetts General Hospital. NEJM. 2007;356(25):2631-37.

2. Stein DM, Robbins J, Miller MA, Lin FYC. Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology? A Review. Vaccine. 2006;24:221–8.

3. SmithKline Beecham receives OFAC license for Cuban meningitis B vaccine. Economic Eye on Cuba [serial on the Internet]. 1999 July 19-25 [cited 2007 Nov 2]. Available from: http://www.cubatrade.org/eyeonz35.html

4. Centers for Disease Control and Prevention. Serogroup B Meningococcal Disease - Oregon, 1994. MMWR 1995;44:7.

5. State of Washington, Department of Health 2006.

6. Ellis A. El Capitan students treated against meningitis outbreak. Fresno Bee. 2007 Mar 23.